Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03809507 · ClinicalTrials.gov registry record
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
A clinical trial of Analgesics, Opioid, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 895
- Enrollment target
- 1
- Study location
NCT03809507: Completed study of Analgesics, Opioid, sponsored by University of North Carolina, Chapel Hill.
NCT03809507 is a study of Analgesics, Opioid that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 895 participants, above the 289-participant average among 3 other Analgesics, Opioid trials with a reported enrollment target (210% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03809507, a study of Analgesics, Opioid, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 895 participants
- Enrollment target
- 1
- Study location
Study Summary
Under the auspices of the Oral Health Section of the NC Department of Health and Human Services clinician-investigators from the UNC Oral and Maxillofacial Surgery Department are conducting a survey to assess current analgesic prescribing practices in NC with a goal of eventually reaching consensus among clinicians for a wide range of procedures and conditions where pain control is important for successful patient outcomes. We hope that about 850 dentists and 600 physicians will agree to take part in this research study. Participation in this Qualtrics survey e-mailed in mid-February 2019 will take about 15 minutes or less.
Primary Outcome
Qualtrics Survey of NC Clinicians with DEA registration. Yes/No responses for opioid drug prescribing for 2 to 3 scenarios differing by target group of clinicians will be asked of 6 different clinician types, emergency room physicians, general dentists and dental specialists..
Conditions Studied
Interventions
- OTHER Qualtrics survey questions
Study Locations (1)
North Carolina
- University of North Carolina School of Dentistry - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 895 participants |
| Start Date | 2019-04-05 |
| Est. Completion | 2021-08-31 |
What the finished NCT03809507 record still lists
NCT03809507 is an observational study that tracks outcomes without assigning an intervention. The registered 895 participants enrollment target is mid-sized for trials with a published cap, above the 289-participant average among 3 other Analgesics, Opioid trials with a reported enrollment target (210% higher).
The record links to 1 condition, with Analgesics, Opioid appearing as the primary indexed condition, and to 1 intervention - of which Qualtrics survey questions is the first listed.
NCT03809507 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03809507 about?
NCT03809507 is a clinical study titled "A Strategy to Reduce Opioid Drug Prescribing by Clinicians". Under the auspices of the Oral Health Section of the NC Department of Health and Human Services clinician-investigators from the UNC Oral and Maxillofacial Surgery Department are conducting a survey to assess current analgesic prescribing practices in NC with a goal of eventually reaching consensus ...
What is the current status of trial NCT03809507?
This trial is currently completed. The enrollment target is 895 participants. The study started on 2019-04-05. Estimated completion is 2021-08-31.
What conditions does trial NCT03809507 study?
This clinical trial studies the following conditions: Analgesics, Opioid.
What interventions are being tested in trial NCT03809507?
The interventions under investigation include: Qualtrics survey questions (OTHER).
Who is sponsoring clinical trial NCT03809507?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03809507 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Analgesics, Opioid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI